Literature DB >> 18201118

Histologic features and prognosis in pediatric medulloblastoma.

Shalini Verma1, C Jane Tavaré, Floyd H Gilles.   

Abstract

Because individual histologic features in childhood medulloblastoma alter survival likelihood, the recent 4th edition of the World Health Organization (WHO) Classification of Brain Tumors recognizes desmoplastic/nodular medulloblastoma, medulloblastoma with extensive nodularity, large cell medulloblastoma, and anaplastic medulloblastoma, in addition to medulloblastoma with no other distinguishing features. To identify features affecting survival likelihood, we investigated 33 histologic features in 556 childhood tumors diagnosed as medulloblastoma in the Childhood Brain Tumor Consortium (CBTC) database; all features have CBTC verified read-reread reliability and those features important in the classification of medulloblastoma and its WHO variants regardless of their measured reliability. Nineteen features had no effect on survival likelihood, and 8 features were too prevalent or too rare to measure their effect on survival. Nodules, balls, high cell density, and fine fibrillary stroma improved survival likelihood; necrosis and prominent nucleoli worsened survival likelihood. Of note, the presence of desmoplasia, currently a defining feature (along with nodules) for desmoplastic/nodular medulloblastoma, had no effect on survival likelihood. We conclude that the presence of nodularity in medulloblastoma is important to improved survival likelihood, particularly when combined with balls and fine fibrillary stroma. Given the "overlap" of desmoplastic/nodular medulloblastoma and nodular medulloblastoma, we suggest they be combined into a diagnosis of nodular medulloblastoma, with nodules, balls, and fine fibrillary stroma as defining criteria. We also suggest that because of the considerable overlap of anaplastic medulloblastoma and large cell medulloblastoma they be combined into 1 diagnosis of anaplastic/large cell medulloblastoma, with necrosis and prominent nucleoli among the defining criteria.

Entities:  

Mesh:

Year:  2008        PMID: 18201118     DOI: 10.2350/07-09-0353.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  7 in total

1.  Magnetic resonance imaging spectrum of medulloblastoma.

Authors:  Julia Fruehwald-Pallamar; Stefan B Puchner; Andrea Rossi; Maria L Garre; Armando Cama; Claus Koelblinger; Anne G Osborn; Majda M Thurnher
Journal:  Neuroradiology       Date:  2011-01-29       Impact factor: 2.804

Review 2.  Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee.

Authors:  Katherine E Warren; Gilbert Vezina; Tina Y Poussaint; Monika Warmuth-Metz; Marc C Chamberlain; Roger J Packer; Alba A Brandes; Moshe Reiss; Stewart Goldman; Michael J Fisher; Ian F Pollack; Michael D Prados; Patrick Y Wen; Susan M Chang; Christelle Dufour; David Zurakowski; Rolf D Kortmann; Mark W Kieran
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

3.  Chemotherapy increases long-term survival in patients with adult medulloblastoma--a literature-based meta-analysis.

Authors:  Selin Kocakaya; Christoph Patrick Beier; Dagmar Beier
Journal:  Neuro Oncol       Date:  2015-09-10       Impact factor: 12.300

4.  Tumor necrosis-initiated complement activation stimulates proliferation of medulloblastoma cells.

Authors:  Adrian J Maurer; Phillip A Bonney; Lucas C Toho; Chad A Glenn; Shweta Agarwal; James D Battiste; Kar-Ming Fung; Michael E Sughrue
Journal:  Inflamm Res       Date:  2015-01-22       Impact factor: 4.575

5.  Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor.

Authors:  Andrew M Heitzer; Alexandra M Villagran; Kimberly Raghubar; Austin L Brown; Miranda L Camet; M Douglas Ris; Jenny H Hanning; M Fatih Okcu; Arnold C Paulino; Murali Chintagumpala; Lisa S Kahalley
Journal:  J Neurooncol       Date:  2019-11-28       Impact factor: 4.130

6.  The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma.

Authors:  Eric M Thompson; Nathaniel L Whitney; Y Jeffrey Wu; Edward A Neuwelt
Journal:  J Neurosurg Pediatr       Date:  2012-10-19       Impact factor: 2.375

7.  Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma.

Authors:  Archya Dasgupta; Tejpal Gupta; Madan Maitre; Babusha Kalra; Abhishek Chatterjee; Rahul Krishnatry; Jayant Sastri Goda; Neelam Shirsat; Sridhar Epari; Ayushi Sahay; Amit Janu; Sona Pungavkar; Girish Chinnaswamy; Vijay Patil; Aliasgar Moiyadi; Prakash Shetty; Rakesh Jalali
Journal:  Strahlenther Onkol       Date:  2022-01-21       Impact factor: 3.621

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.